Hako-Med GmbH: A Leader in Horizontal Therapy and Electromedicine
Hako-Med GmbH is a German company that has established itself as a pioneer in the field of electromedicine. Founded in the 1980s by Dr. Achim Hansjurgens, a bioelectric medicine and engineering expert, the company's core business is the development, manufacturing, and distribution of advanced electromedical devices. Hako-Med's primary contribution to the field is its patented treatment concept known as Horizontal Therapy (HT). This therapy is a significant advancement over traditional electrotherapy methods because it is designed to simultaneously address both the bioelectrical and biochemical aspects of cellular communication.
The fundamental principle behind Hako-Med's technology lies in the understanding of how cells communicate. In a healthy body, all cells, whether in bone, muscle, ligament, or nerve tissue, communicate through both electrical signals and chemical messengers. When this communication is impaired, it can lead to pain, disease, and a loss of normal function. While older electrotherapy methods, such as TENS therapy, electrical muscle stimulation, and interferential therapy, could influence one of these communication pathways, none were capable of affecting both at the same time. Hako-Med's Horizontal Therapy overcomes this limitation by using unique, proprietary waveforms and specific electrical signals to generate both bioelectric and biochemical effects within the same tissue during a single treatment session. This dual-action approach is what distinguishes Hako-Med's devices and is marketed as "High-Frequency Medicine."
Continue…The company's flagship product is the ProElec DT 2000 series, a sophisticated, professional-grade system engineered for clinical use by physicians, chiropractors, and other pain management and rehabilitation specialists. The device uses specific electrical parameters?including frequencies, amplitudes, and frequency changes?to influence target tissues at the cellular level. By adjusting the frequency while maintaining a steady electrical intensity, the device can achieve a broad spectrum of physiological outcomes. At lower frequencies, the therapy primarily influences bioelectric processes, which can improve circulation, lymphatic flow, and muscle function, and provide pain relief. At higher frequencies, it targets biochemical processes, which can enhance metabolism, immune system function, and overall healing.
Hako-Med's Horizontal Therapy and its associated devices have been developed to treat a wide range of acute and chronic pain conditions. The list of conditions successfully addressed with this therapy is extensive and includes:
- Chronic and acute back pain and neck pain, including issues like herniated discs and spinal stenosis.
- Peripheral neuropathy, a condition that causes numbness, tingling, and pain, particularly in the extremities. The therapy works by stimulating nerve repair and enhancing circulation.
- Fibromyalgia and myofascial pain syndrome, providing relief from widespread pain and discomfort.
- Joint pain and swelling related to conditions such as osteoarthritis, rheumatoid arthritis, and other degenerative diseases.
- Various types of headaches, including migraines and tension headaches.
- Nerve pain, such as sciatica, radiculopathy, and trigeminal neuralgia.
- Post-operative pain and sports injuries, aiding in the healing process and reducing inflammation and swelling.
- Tendonitis, muscle spasms, and other musculoskeletal conditions.
The treatments are non-invasive and non-pharmaceutical, with most patients experiencing a painless, tingling sensation during the approximately 30-45 minute sessions. The devices have received the necessary regulatory clearances, including FDA 510(k) clearance in the United States, where Hako-Med has maintained a continuous presence through distributors like Hako-Med Holdings, Inc.
In recent years, Hako-Med has expanded its product line to make its therapy more accessible to patients. This includes the development of the ProElecDT Regenerator, a portable and more affordable version of its clinical devices. The Regenerator is designed for at-home use, allowing patients to continue their treatment regimens daily, which can amplify the results achieved from in-office sessions. This move represents Hako-Med's commitment to overcoming the limitations of in-office-only treatment and empowering patients with a prescription-strength, take-home option.
In summary, Hako-Med GmbH is a key player in the electromedicine industry, distinguished by its unique and patented Horizontal Therapy. Through its flagship ProElec DT 2000 and newer ProElecDT Regenerator devices, the company offers a comprehensive, non-invasive solution for a broad spectrum of pain and degenerative conditions by addressing both the bioelectrical and biochemical aspects of cellular health.
